The Library
Guideline for the screening and treatment of retinopathy of prematurity
Tools
Royal College of Paediatrics and Child Health, Royal College of Ophthalmologists, British Association of Perinatal Medicine, BLISS (Including: UNSPECIFIED). (2008) Guideline for the screening and treatment of retinopathy of prematurity. London: Royal College of Paediatrics and Child Health.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Abstract
Retinopathy of prematurity (ROP) is one of the few causes of childhood visual disability which is
largely preventable. Many extremely preterm babies will develop some degree of ROP although
in the majority this never progresses beyond mild disease which resolves spontaneously without
treatment. A small proportion, develop potentially severe ROP which can be detected through retinal
screening. If untreated, severe disease can result in serious vision impairment and consequently all
babies at risk of sight-threatening ROP should be screened.
This evidence-based guideline for the screening and treatment of ROP was developed by a
multidisciplinary guideline development group (GDG) of the Royal College of Paediatrics & Child
Health (RCPCH) in collaboration with the Royal College of Ophthalmologists (RCOphth), British
Association of Perinatal Medicine (BAPM) and the premature baby charity BLISS. The guideline
was produced according to RCPCH standards for guideline development.
1
The guideline provides 25 evidence-based recommendations and 21 good practice points.
Recommendations are graded A-D using SIGN grading hierarchy,
2
according to the strength of the
evidence underpinning them. The good practice points (GPP) are a consensus of the GDG. This
Executive Summary highlights those recommendations and good practice points considered by the
GDG to be priorities for implementation.
This guideline has been produced specifically for use within the UK and supersedes the previous
guideline.
3
It will not be applicable in countries where more mature babies are at risk of sight
threatening ROP.
4
Not all the recommendations are included in this Summary. The full Guideline should be consulted
which also contains complete details of the Guideline methodology. Appendices A, B, C and D
give a standardised sheet for recording screening results, an algorithm for ophthalmic criteria for
screening and treatment, the International Classification of ROP Revisited, and parent information
leaflets respectively. All the documents are available on the websites of the Royal College of
Ophthalmologists www.rcophth.ac.uk, the Royal College of Paediatrics and Child Health www.
rcpch.ac.uk/ROP or the British Association of Perinatal Medicine www.bapm.org.
The guideline will be updated within five years of its publication date.
Item Type: | Report | ||||
---|---|---|---|---|---|
Subjects: | R Medicine > R Medicine (General) | ||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences > Mental Health and Wellbeing Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
Publisher: | Royal College of Paediatrics and Child Health | ||||
Place of Publication: | London | ||||
Official Date: | May 2008 | ||||
Dates: |
|
||||
Number of Pages: | 82 | ||||
Status: | Not Peer Reviewed | ||||
Publication Status: | Published | ||||
Description: | Guideline Development Group RCPCH: Head, K., Davis, K. and Fitzgerald, P. |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |